City

Zurich (2)

Aarau (1)

Horgen (1)

Mainz (1)

Monchengladbach (1)

Rapperswil-Jona (1)

Saint Gallen (1)

Condition

Biosimilar (1)

Breast Cancer (1)

Breast Neoplasm (1)

Breast Neoplasms (1)

CAR T-Cell Therapy (1)

HER2-positive Breast Cancer (1)

Patient Reported Outcome (1)

Patient Reported Outcome Measures (1)

Overall Status

Recruiting (2)

Active, not recruiting (1)

Not yet recruiting (1)

Terminated (1)

Phase

n/a (1)

phase 2 (1)

phase 4 (1)

Sponsor

Palleos Healthcare GmbH (3)

OnkoZentrum Zurich AG (1)

Stiftung Swiss Tumor Institute (1)

Study Documents

Intervention Type

device (2)

drug (2)

diagnostic test (1)

procedure (1)

Funder Type

Industry (3)

Other (2)

Study Type

Interventional (3)

Observational (2)

palleos

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

HER2-directed Biosimilar in Breast Cancer: Real World ePRO

Recruiting

HER2-positive Breast Cancer
+2 more

Horgen, Zurich, Switzerland
+4 more

Oct 3, 2022

Side Effects in Cancer Patients Undergoing CAR T Immunotherapy

Recruiting

Patient Reported Outcome Measures
CAR T-Cell Therapy

Consilium CareTM

Zürich, Switzerland

Klinik für Hämatologie und Onkologie

Apr 29, 2022

Breast Cancer Trial (consilium care™ app)

Not yet recruiting

Breast Cancer

consilium care™ app

(no location specified)

Jun 16, 2022

Breast Tumor Trial in Mainz (Palbociclib, Fulvestrant, Anastrozole)

Terminated

Breast Neoplasm

Palbociclib
+4 more

Mainz, Germany

University Hospital Mainz

Dec 16, 2021

Breast Tumors Trial in Mönchengladbach (drug, diagnostic test, procedure)

Active, not recruiting

Breast Neoplasms

Perjeta Injectable Product
+13 more

Mönchengladbach, Germany

Evangelisches Krankenhaus Bethesda Mönchengladbach

Oct 4, 2022